Mitral stenosis resident survival guide: Difference between revisions
Line 85: | Line 85: | ||
{{familytree | | |`|-|v|-|'| | | |!| | | | | |!| | | | | | | |!| | | | | |!| | | | | }} | {{familytree | | |`|-|v|-|'| | | |!| | | | | |!| | | | | | | |!| | | | | |!| | | | | }} | ||
{{familytree | | | | D01 | | | | D02 | | | | D03 | | | | | | D04 | | | | D05 | | | | | | | |D01= <div style="float: left; text-align: left; width: 8em; padding:1em;">❑ Assess if valve morphology is favorable for PMBC</div>|D02=<div style="float: left; text-align: left; width: 8em; padding:1em;">❑ Perform exercise testing </div>|D03=<div style="float: left; text-align: left; width: 8em; padding:1em;">❑ Assess if valve morphology is favorable for PMBC</div>|D04=<div style="float: left; text-align: left; width: 8em; padding:1em;">❑ Assess if valve morphology is favorable for PMBC</div>|D05=<div style="float: left; text-align: left; width: 8em; padding:1em;">❑ Monitor patient periodically</div>}} | {{familytree | | | | D01 | | | | D02 | | | | D03 | | | | | | D04 | | | | D05 | | | | | | | |D01= <div style="float: left; text-align: left; width: 8em; padding:1em;">❑ Assess if valve morphology is favorable for PMBC</div>|D02=<div style="float: left; text-align: left; width: 8em; padding:1em;">❑ Perform exercise testing </div>|D03=<div style="float: left; text-align: left; width: 8em; padding:1em;">❑ Assess if valve morphology is favorable for PMBC</div>|D04=<div style="float: left; text-align: left; width: 8em; padding:1em;">❑ Assess if valve morphology is favorable for PMBC</div>|D05=<div style="float: left; text-align: left; width: 8em; padding:1em;">❑ Monitor patient periodically</div>}} | ||
{{familytree | |,|-|-|^|.| | | | |!| | | | | {{familytree | |,|-|-|^|.| | | | |!| | | | | |)|-|-|-|.| | | |)|-|-|-|.| | | | | | | }} | ||
{{familytree | E01 | | E02 | | | E03 | | E04 | | E05 | | E06 | | E07 | | | {{familytree | E01 | | E02 | | | E03 | | | | E04 | | E05 | | E06 | | E07 | | | |E01=Yes|E02=No|E03=❑ Assess if [[PCWP]] > 25 mm Hg on exercise|E04=Yes|E05=No|E06=No|E07=Yes}} | ||
{{familytree | |!| | | |!| | | | |!| | | | | {{familytree | |!| | | |!| | | | |!| | | | | |!| | | |`|-|v|-|'| | | |!| | | | | }} | ||
{{familytree | F01 | | F02 | | | F03 | | | | | | | | | | | | | {{familytree | F01 | | F02 | | | F03 | | | | F04 | | | | F05 | | | | F06 | | | |F01=<div style="float: left; text-align: left; width: 8em; padding:1em;">❑ Proceed with PMBC </div>|F02=<div style="float: left; text-align: left; width: 8em; padding:1em;">❑ Assess if patient is severely symptomatic (NYHA III/IV)<br>❑ Assess if the risk of surgery is high</div>|F03=<div style="float: left; text-align: left; width: 8em; padding:1em;">❑ Proceed with PMBC if [[PCWP]] > 25 mm Hg<br>❑ Monitor patient periodically if [[PCWP]]< 25 mm Hg </div>|F04=❑ Proceed with PMBC|F05=❑ Monitor patient periodically|F06=❑ Assess for the presence of new onset [[AF]]|F07=❑ Monitor patient periodically}} | ||
{{familytree | | | |,|-|^|-|.| | | | | | | | | | | | | | | | | | | | | | | | | | }} | {{familytree | | | |,|-|^|-|.| | | | | | | | | | | | | | | | | | | | | | | | | | }} | ||
{{familytree | | | G01 | | G02 | | | | | | | | | | | | | | | | | | | | | | | | |G01= Yes|G02=No}} | {{familytree | | | G01 | | G02 | | | | | | | | | | | | | | | | | | | | | | | | |G01= Yes|G02=No}} |
Revision as of 19:57, 10 March 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Definition
Mitral stenosis refers to abnormal narrowing of mitral orifice which leads to obstruction of blood flow from left atrium to left ventricle and development of a pressure gradient between the two chambers.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Common Causes
Initial Evaluation
Shown below is an algorithm summarizing the approach to [[disease name]].
Characterize the symptoms: ❑ Exercise intolerance | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Examine the patient:
Head:
Neck: Chest:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Management
❑Assess the presence of symptoms | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Symptomatic | Asymptomatic | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
❑ Assess the severity of mitral stenosis | ❑ Assess the severity of mitral stenosis | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Very severe | Severe | Moderate | Very severe | Severe | Moderate | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
❑ Assess if valve morphology is favorable for PMBC | ❑ Perform exercise testing | ❑ Assess if valve morphology is favorable for PMBC | ❑ Assess if valve morphology is favorable for PMBC | ❑ Monitor patient periodically | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ❑ Assess if PCWP > 25 mm Hg on exercise | Yes | No | No | Yes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
❑ Proceed with PMBC | ❑ Assess if patient is severely symptomatic (NYHA III/IV) ❑ Assess if the risk of surgery is high | ❑ Proceed with PMBC | ❑ Monitor patient periodically | ❑ Assess for the presence of new onset AF | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
❑ Proceed with PMBC | ❑ Proceed with mitral valve surgery | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Additional Management
Medical therapy ❑ Consider heart rate control in MS patients with:
❑ Consider anticoagulation therapy in MS patients with:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||